Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan effects on lipid subfractions in hypertension with metabolic syndrome
NCT00394745Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Nov 2005; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00394745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394745.